Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | -0.61% | +3.14% | -33.60% |
Apr. 23 | Citigroup Adjusts Expensify's Price Target to $4 From $5, Keeps Buy Rating | MT |
Apr. 17 | Expensify Insider Bought Shares Worth $466,734, According to a Recent SEC Filing | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The stock, which is currently worth 2024 to 0.75 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-33.60% | 141M | - | ||
+6.12% | 3,039B | C+ | ||
+2.95% | 80.47B | B | ||
+1.73% | 75.69B | B+ | ||
-15.70% | 54.73B | B+ | ||
-16.59% | 51.62B | B- | ||
+26.44% | 47.77B | D+ | ||
+15.81% | 40.95B | D+ | ||
+55.14% | 35.86B | D+ | ||
-10.89% | 24.36B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EXFY Stock
- Ratings Expensify, Inc.